Researchers evaluate outcomes of SD and PD in patients with GISTs

NewsGuard 100/100 Score

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for GIST. Numerous procedures can be performed to remove duodenal GIST. Some of these operations are extensive and require difficult reconstruction (like pancreaticoduodenectomy; PD). One of the options is a more limited intervention: segmental duodenectomy (SD). However, few studies have correlated the different surgical options with the oncological results.

A research article to be published on June 14, 2010 in the World Journal of Gastroenterology addresses this question. A Switzerland research group has conducted this study to evaluate the outcomes after SD and PD. They found that SD was a reliable and curative option for most duodenal GISTs, and was compatible with long-term disease-free survival (DFS). On the other hand, PD remains a good alternative for tumors in the vicinity of the pancreas.

In the present study, the authors report good oncological outcomes with long-term DFS in the SD group. Thus, whenever associated with clear surgical margins, SD is a reliable and curative option for most duodenal GISTs.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis